Nicotine e-cigarettes outperform patches and gum for quitting smoking

Researchers have found that nicotine e-cigarettes help more smokers quit than traditional nicotine replacement therapies like patches and gum. A review of 14 systematic studies from 2014 to 2023 shows consistent high-quality evidence favoring nicotine vapes. The findings highlight gaps in research on long-term risks and comparisons to other treatments.

A team led by Dr. Angela Difeng Wu from the University of Oxford's Nuffield Department of Primary Care Health Sciences analyzed 14 systematic reviews on smoking cessation methods. The highest-quality studies consistently demonstrated higher quit rates with nicotine e-cigarettes compared to nicotine patches, gum, lozenges, non-nicotine e-cigarettes, and behavioral support programs alone. Lower-quality research showed more mixed results, but the strongest evidence supports nicotine e-cigarettes as more effective. The work, published in the journal Addiction, was funded by Cancer Research UK. Dr. Wu stated, 'We hope this overview and Evidence and Gap Map can lay to rest some claims that evidence is mixed regarding the impacts of nicotine e-cigarettes on smoking abstinence. In fact, the evidence is clear and consistent across all of the meta-analyses we consulted: e-cigarettes are effective at helping people stop smoking.' Researchers created an Evidence and Gap Map to identify research needs. No high-quality reviews compare nicotine e-cigarettes to cytisine, bupropion, or nicotine pouches, and evidence against varenicline comes from just one small, high-bias study. Data on serious adverse events remains uncertain, and most studies focus on high-income countries. The authors call for more research on risks and diverse populations.

Relaterede artikler

Drug commissioner Hendrik Streeck at press conference urging ban on sweet-flavored e-cigarettes to safeguard youth from addiction.
Billede genereret af AI

Narkotikakommissær Streeck kræver forbud mod søde smagsstoffer i e-cigaretter

Rapporteret af AI Billede genereret af AI

Regeringens narkotikakommissær Hendrik Streeck går ind for forbud mod søde smage i e-cigaretter for at beskytte unge. Han kritiserer markedsføringen som en afhængighedsstrategi og byder planned forbud mod 13 ingredienser velkommen. Afhængighedsforskeren Heino Stöver finder dog tiltagene ubeføjelige.

Law 2354 of 2024 aims to regulate nicotine electronic systems and similar products, but its implementation faces significant delays. Two years after promulgation, key provisions like mandatory labeling and advertising bans remain unenforced. This allows uncontrolled circulation of vapes among teens, per Ministry of Justice data.

Rapporteret af AI

China's State Tobacco Monopoly Administration released a draft policy on Thursday to reduce excess capacity in the e-cigarette sector and tighten enforcement of production and export standards. This follows a State Council opinion earlier this month that imposed stricter oversight on e-cigarettes and nicotine pouches.

En ny undersøgelse fra University of Gothenburg viser, at tirzepatid, det aktive stof i diabetes- og vægttabsmedicin Mounjaro, reducerer alkoholindtag og tilbagefaldslignende adfærd hos rotter og mus. Dette bygger på tidligere forskning om semaglutid i Ozempic og Wegovy, som dæmper alkoholforbrug hos mennesker. Forskere håber på lignende effekter hos patienter med alkoholafhængighed.

Rapporteret af AI

A new review of clinical trials suggests that psychedelics like psilocybin are effective for treating depression but offer no advantage over traditional antidepressants. Researchers accounted for the challenge of blinding in psychedelic studies, where participants can often tell if they received the drug. The findings indicate similar outcomes when compared to unblinded antidepressant trials.

A comprehensive review of clinical trials suggests that cannabis products high in THC may provide modest, short-term relief for chronic pain, especially neuropathic types, but with notable side effects. In contrast, CBD-dominant products offer no clear advantages. Researchers call for more long-term studies to assess safety and efficacy.

Rapporteret af AI

Fra april kan tungrøgere i alderen 50 til 75 år i Tyskland få en årlig gratis lungekræftscreening. Programmet bruger lavdosis computertomografi til at opdage kræft tidligt. Det retter sig mod nuværende og tidligere røgere med mindst 15 pakkeår.

 

 

 

Dette websted bruger cookies

Vi bruger cookies til analyse for at forbedre vores side. Læs vores privatlivspolitik for mere information.
Afvis